References
- Merlin MD. Archaeological evidence for the tradition of psychoactive plant use in the old world. Econ Bot. 2003;57(3):295–323.
- Gibbons S, Arunotayanun W. Natural product (fungal and herbal) novel psychoactive substances In: Novel Psychoactive Substances. London: Academic Press; 2013.
- Internationl Narcotics Control Board. Report of the International Narcotics Control Board for 2010 New York 2011.
- Feng LY, Battulga A, Han E, et al. New psychoactive substances of natural origin: a brief review. J Food Drug Anal. 2017;25(3):461–471.
- Schmidt MM, Sharma A, Schifano F, et al. Legal highs” on the net-evaluation of UK-based websites, products and product information. Forensic Sci Int. 2011;206(1–3):92–97.
- United Nations Office on Drugs and Crime. The challenge of new psychoactive substances. Vienna, Austria; 2013 [cited 2019 Aug 6] Available from: https://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf.
- Richardson WH, Slone CM, Michels JE. Herbal drugs of abuse: an emerging problem. Emerg Med Clin North Am. 2007;25(2):435–457. Abstract ix.
- Dasgupta A. Challenges in laboratory detection of unusual substance abuse: issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent abuse. Adv Clin Chem. 2017;78:163–186.
- Walsh C. Drugs, the internet and change. J Psychoact. Drugs. 2011;43(1):55–63.
- Onders B, Casavant MJ, Spiller HA, et al. Marijuana exposure among children younger than six years in the United States. Clin Pediatr (Phila). 2016;55(5):428–436.
- ProCon.org. 33 Legal medical Marijuana states and DC: laws, fees, and possession limits. 2018 [cited 2019 Aug 6]. Available from: https://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.
- Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004;102(2):131–138.
- Ujvary I. Psychoactive natural products: overview of recent developments. Ann Ist Super Sanita. 2014;50(1):12–27.
- Forrester MB. Jimsonweed (Datura stramonium) exposures in Texas, 1998–2004. J Toxicol Environ Health A. 2006;69(19):1757–1762.
- Carstairs SD, Cantrell FL. Peyote and Mescaline exposures: a 12-year review of a statewide poison center database. Clin Toxicol (Phila). 2010;48(4):350–353.
- Carstairs SD, Cantrell FL. The spice of life: an analysis of Nutmeg exposures in California. Clin Toxicol (Phila). 2011;49(3):177–180.
- Kintziger KW, Mulay P, Watkins S, et al. Wild mushroom exposures in Florida, 2003–2007. Public Health Rep. 2011;126(6):844–852.
- Vohra R, Seefeld A, Cantrell FL, et al. Salvia divinorum: exposures reported to a statewide poison control system over 10 years. J Emerg Med. 2011;40(6):643–650.
- Forrester MB, Kleinschmidt K, Schwarz E, et al. Synthetic cannabinoid and Marijuana exposures reported to poison centers. Hum Exp Toxicol. 2012;31(10):1006–1011.
- Forrester MB. Kratom exposures reported to Texas poison centers. J Addict Dis. 2013;32(4):396–400.
- Ehrenpreis JE, DesLauriers C, Lank P, et al. Nutmeg poisonings: a retrospective review of 10 years experience from the Illinois poison center, 2001–2011. J Med Toxicol. 2014;10(2):148–151.
- Mrazova K, Navratil T, Pelclova D. Use and accidental exposure to hallucinogenic agents reported to the Czech Toxicological Information Centre from 1995 to 2008. Subst Use Misuse. 2011;46(4):460–465.
- Gummin DD, Mowry JB, Spyker DA, et al. 2016 annual report of the American association of poison control centers’ National Poison Data System (NPDS): 34th annual report. Clin Toxicol (Phila). 2017;55(10):1072–1252.
- US Census Bureau. National Intercensal Datasets: 2000–2010. 2010 [cited 2019 Aug 6]. Available from: https://www.census.gov/data/datasets/time-series/demo/popest/intercensal-2000-2010-national.html.
- US Census Bureau. National Population by Characteristics: 2010–2017. 2017 [cited 2019 Aug 6]. Available from:https://www.census.gov/data/datasets/2017/demo/popest/nation-detail.html.
- National Institutes of Health Office of Dietary Supplements. FDA issues consumer advisory for dietary supplements containing Kava. 2018 [cited 2019 Aug 6]. Available from: https://ods.od.nih.gov/Health_Information/kava.aspx.
- Stogner J, Khey DN, Griffin OH, et al. Regulating a novel drug: an evaluation of changes in use of Salvia divinorum in the first year of Florida’s ban. Int J Drug Policy. 2012;23(6):512–521.
- Tulve NS, Suggs JC, McCurdy T, et al. Frequency of mouthing behavior in young children. J Expo Sci Environ Epidemiol. 2002;12(4):259–264.
- Richards JR, Smith NE, Moulin AK. Unintentional Cannabis ingestion in children: a systematic review. J Pediatr. 2017;190:142–152.
- Peiper NC, Ridenour TA, Hochwalt B, et al. Overview on prevalence and recent trends in adolescent substance use and abuse. Child Adolesc Psychiatr Clin N Am. 2016;25(3):349–365.
- Han B, Compton WM, Blanco C, et al. National trends in substance use and use disorders among youth. J Am Acad Child Adolesc Psychiatry. 2017;56(9):747–754.e3.
- Grucza RA, Krueger RF, Agrawal A, et al. Declines in prevalence of adolescent substance use disorders and delinquent behaviors in the USA: a unitary trend? Psychol Med. 2018;48(9):1494–1503.
- National Institute on Drug Abuse. National Survey on Drug Use and Health: Trends in Prevalence of Various Drugs for Ages 12 or Older, Ages 12 to 17, Ages 18 to 25, and Ages 26 or Older; 2015–2017 (in percent)*. Maryland, USA; 2019 [cited 2019 Oct 10]. Available from: https://www.drugabuse.gov/national-survey-drug-use-health.
- Steinberg L. Risk taking in adolescence: new perspectives from brain and behavioral science. Curr Dir Psychol Sci. 2007;16(2):55–59.
- Anwar M, Law R, Schier J. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers – United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(29):748–749.
- Post S, Spiller HA, Chounthirath T, et al. Kratom exposures reported to United States poison control centers: 2011–2017. Clin Toxicol (Phila). 2019;57(10):847–854.
- U.S. Food and Drug Administration. FDA 101: Dietary Supplements. Maryland, USA; 2015 [cited 2019 Aug 6]. Available from: https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements.
- United States Drug Enforcement Administration. DEA Announces intent to schedule Kratom: SE Asian drug is imminent hazard to public safety. Springfield, USA; 2016 [cited 2019 Aug 6]. Available from: https://www.dea.gov/press-releases/2016/08/30/dea-announces-intent-schedule-kratom.
- United States Drug Enforcement Administration. Withdrawal of notice of intent to temporarily place Mitragynine and 7-Hydroxymitragynine into schedule 1. Federal Register. Springfield, USA; 2016.
- Borchardt JK. Ohio could soon ban plant-based supplement used to treat pain, opioid addiction. Columbia, USA; 2018 [cited 2019 Aug 6]. Available from: https://www.cincinnati.com/story/news/2018/10/01/ohio-could-soon-ban-kratom-products/1491649002/.
- Kruegel AC, Grundmann O. The medicinal chemistry and neuropharmacology of Kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. 2018;134(Pt A):108–120.
- Henningfield JE, Fant RV, Wang DW. The abuse potential of Kratom according the 8 factors of the controlled substances act: implications for regulation and research. Psychopharmacology (Berl). 2018;235(2):573–589.